McKesson to pay $150m after alleged failure to report suspicious orders
The distribution giant, McKesson Corporation, has agreed to pay the DEA's record fine of $150m after allegedly failing to report “suspicious orders” for controlled substances.
The distribution giant, McKesson Corporation, has agreed to pay the DEA's record fine of $150m after allegedly failing to report “suspicious orders” for controlled substances.
Biosimilar interchangeability
The US FDA expects biosimilar developers to provide data from switching studies to demonstrate interchangeability with a reference biologic in draft guidance published today.
Problems at a CMO have forced Janssen-Cilag to ship Haldol made in Austria to patients in Switzerland to maintain supplies.
Technology is catapulting clinical trials into a 'new era' as scientific breakthroughs bring new opportunities to an industry that has traditionally lacked innovation.
Horizon Discovery Group has extended its CRISPR technology license to improve the performance of CHO cell lines for biomanufacturing.
Exco InTouch has formally received certification demonstrating it meets certain data privacy and security principles.
The Chapel Hill, NC-based contract research organization (CRO) has implemented PhlexEview4 as its preferred eTMF solution to support commercial and government clients.
Siemens and GEA have developed a continuous manufacturing platform for pharmaceuticals that integrates the former’s quality control software.